Qarzning balans qiymatiga nisbati: TransCode Therapeutics Inc. (RNAZ)

TransCode Therapeutics Inc. (RNAZ) tovar belgisi

TransCode Therapeutics (RNAZ) tadqiqot etikasi qoidalariga rioya qilgan holda, saratonga qarshi dori vositalarini ishlab chiqishga ESG tamoyillarini joriy qilmoqda. Kompaniya metastazlarga qarshi kurashish uchun RNA terapiyasiga e'tibor qaratmoqda va yirik sog'liqni saqlash gigantlarining qiziqishini kutmoqda. Foyda yo'qligi sharoitida yuqori xarajatlar qat'iy boshqaruvni talab qiladi. Qarzning kapitalga nisbati grafigi qarz yukini ko'rsatadi, bunda ushbu ko'rsatkich 0.00 ga tengdir.

TransCode Therapeutics, Inc. (RNAZ): Qarzning sof aktivlarga nisbati 04.07.2022dan 26.10.2026gacha

transcodetherapeutics.com (RNAZ) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi TransCode Therapeutics, Inc.|RNAZ - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor bahosi TransCode Therapeutics|RNAZ - Biznesning umumiy qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar TransCode Therapeutics|RNAZ - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati transcodetherapeutics.com|RNAZ - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati TransCode Therapeutics|RNAZ - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Qisqa muddatli qarzning o'z kapitaliga nisbati TransCode Therapeutics, Inc.|RNAZ - Kompaniyaning umumiy qarz majburiyatlari|Balans kapitallashuviga qarzlar TransCode Therapeutics
Kompaniyaning fundamental tahlili:TransCode (RNAZ)
TransCode Therapeutics, Inc. seriyali mahsuloti

Investorlar TransCode Therapeutics (RNAZ) barqarorligini qarz kapitali va aksiyalar o'rtasidagi muvozanat orqali baholaydilar. Klinik sinovlar va patent himoyasi bilan bog'liq yuqori xarajatlar likvidlikni aniq boshqarishni taqozo etadi. Ushbu ko'rsatkich umumiy majburiyatlarni aktivlarning balans qiymati bilan bog'laydi. Balans kapitaliga asoslangan moliyaviy qaramlik darajalarini tahlil qilish orqali qarz yukining darajasini aniqlash mumkin. Ushbu koeffitsiyentning pasayishi kengayish strategiyasini amalga oshirish davrida moliyaviy avtonomiyani tasdiqlaydi.

TransCode Therapeutics kimlar bilan raqobatlashadi

Balans kapitallashuviga qarzlar TEM (Tempus AI Inc)|QGEN - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Ionis IONS|RGEN: Qarzning balans kapitaliga nisbati|Qarzning balans kapitallashuviga nisbati Avidity RNA|CRISPR (CRSP) - Qarzning sof aktivlarga nisbati|WGS (GeneDx Holdings Corp.) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar RARE|Qarzning balans kapitallashuviga nisbati Beam Therapeutics BEAM|Qarzning balans qiymatiga nisbati SRPT (Sarepta Therapeutics)|Qarzning balans kapitallashuviga nisbati TWST|Sof aktivlarga qarzlar 10x TXG|NTLA: Balans kapitallashuviga qarzlar|STOK: Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati BLFS|Wave Life Sciences Ltd (WVE) - Balans qiymatiga qarzlar|Balans kapitallashuviga qarzlar Maze Tx (MAZE)|Qarzning balans qiymatiga nisbati Sionna Corp|Prime Medicine, Inc. - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar tayshagtx.com TSHA|Qarzning balans qiymatiga nisbati uniQure|MGTX - Qarzning sof aktivlarga nisbati|Qarzning balans qiymatiga nisbati Regenxbio RGNX|SLDB - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar Ocugen, Inc. OCGN|pacb.com (PACB) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar BNTC (Benitec Biopharma)|Balans qiymatiga qarzlar DSGN|Rocket Pharmaceuticals Inc (RCKT) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati 4D Molecular Corp (FDMT)|Balans kapitallashuviga qarzlar LXEO (Lexeo Therapeutics, Inc.)|Korro Bio Inc. - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Editas Medicine|SLN - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar PRQR|Balans qiymatiga qarzlar Codexis|SGMO (Sangamo Therapeutics) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar Nautilus Biotechnology Inc (NAUT)|Qarzning balans qiymatiga nisbati Metagenomi|Qarzning balans kapitaliga nisbati Precision BioSciences Inc. (DTIL)|Balans kapitallashuviga qarzlar GBIO|Sof aktivlarga qarzlar Boundless Bio Inc BOLD|XCUR: Balans kapitallashuviga qarzlar|IMNN: Qarzning balans qiymatiga nisbati|phiopharma.com - Qarzning balans kapitallashuviga nisbati|MBIO (Mustang Bio) - Sof aktivlarga qarzlar|BNGO - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati APDN|Qarzning balans kapitallashuviga nisbati bluebird bio, Inc. BLUE|Qarzning balans qiymatiga nisbati immunoprecise.com (IPA)|Balans kapitallashuviga qarzlar OMGA (Omega Therapeutics, Inc.)|OMIC - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Regulus Therapeutics Inc|SYRS - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar Telesis Bio, Inc.|TCON (traconpharma.com) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati Unity Biotechnology, Inc. (UBX)